Literature DB >> 23287699

Differences in infectivity and induction of infertility: a comparative study of Chlamydia trachomatis strains in the murine model.

Jennifer R Carmichael1, Delia Tifrea, Sukumar Pal, Luis M de la Maza.   

Abstract

Chlamydia trachomatis, although commonly asymptomatic in women, can result in chronic sequelae, such as pelvic inflammatory disease, ectopic pregnancy and infertility. However, a clear relationship has not been determined between specific serovars and the ability to lead to upper genital tract infection or infertility. Thus, in order to investigate differences in pathogenicity, C3H/HeN mice were infected in the ovarian bursa with the C. trachomatis strains D (UW-3/Cx), F (N.I.1), F (IC-Cal-3) and E (Bour). Differences both in the amount of vaginal shedding as well as subsequent fertility rates were observed between D (UW-3/Cx) and F (N.I.1) compared to F (IC-Cal-3) and E (Bour). Approximately 50% of the mice infected with the D (UW-3/Cx) and F (N.I.1) strains had vaginal shedding for up to 3-4 weeks after infection and fertility rates of less than 25%. Furthermore, mice inoculated with D (UW-3/Cx) and F (N.I.1) showed infertility even in the absence of medroxy progesterone acetate (MPA) treatment. In contrast, both MPA and non-MPA treated mice infected with F (IC-Cal-3) or E (Bour) did not show vaginal shedding and had fertility rates between 45 and 88%. Mutations in the CT135 open reading frame have been associated with virulence. However, no nucleotide differences were found among the four isolates for CT135. This murine model of infection with C. trachomatis may help with the understanding of disease pathology in humans and ultimately vaccine development.
Copyright © 2012 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23287699      PMCID: PMC3602122          DOI: 10.1016/j.micinf.2012.12.001

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  46 in total

1.  Urogenital Chlamydia trachomatis serovars in men and women with a symptomatic or asymptomatic infection: an association with clinical manifestations?

Authors:  S A Morré; L Rozendaal; I G van Valkengoed; A J Boeke; P C van Voorst Vader; J Schirm; S de Blok; J A van Den Hoek; G J van Doornum; C J Meijer; A J van Den Brule
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Effect of inflammatory response on in vivo competition between two chlamydial variants in the guinea pig model of inclusion conjunctivitis.

Authors:  Roger G Rank; Anne K Bowlin; Kati I Tormanen; Yin Wang; Anthony T Maurelli
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

Review 3.  The cellular paradigm of chlamydial pathogenesis.

Authors:  Richard S Stephens
Journal:  Trends Microbiol       Date:  2003-01       Impact factor: 17.079

4.  Longitudinal assessment of infecting serovars of Chlamydia trachomatis in Seattle public health clinics: 1988-1996.

Authors:  Robert J Suchland; Linda O Eckert; Stephen E Hawes; Walter E Stamm
Journal:  Sex Transm Dis       Date:  2003-04       Impact factor: 2.830

5.  Epidemiology and clinical manifestations of unique Chlamydia trachomatis isolates that occupy nonfusogenic inclusions.

Authors:  W M Geisler; R J Suchland; D D Rockey; W E Stamm
Journal:  J Infect Dis       Date:  2001-08-22       Impact factor: 5.226

6.  Infertility in mice infected genitally with a human strain of Chlamydia trachomatis.

Authors:  M Tuffrey; P Falder; J Gale; R Quinn; D Taylor-Robinson
Journal:  J Reprod Fertil       Date:  1986-09

7.  Salpingitis in mice induced by human strains of Chlamydia trachomatis.

Authors:  M Tuffrey; P Falder; J Gale; D Taylor-Robinson
Journal:  Br J Exp Pathol       Date:  1986-08

8.  Prevalence of chlamydial and gonococcal infections among young adults in the United States.

Authors:  William C Miller; Carol A Ford; Martina Morris; Mark S Handcock; John L Schmitz; Marcia M Hobbs; Myron S Cohen; Kathleen Mullan Harris; J Richard Udry
Journal:  JAMA       Date:  2004-05-12       Impact factor: 56.272

Review 9.  The relationship of serovar to clinical manifestations of urogenital Chlamydia trachomatis infection.

Authors:  William M Geisler; Robert J Suchland; William L H Whittington; Walter E Stamm
Journal:  Sex Transm Dis       Date:  2003-02       Impact factor: 2.830

10.  Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis.

Authors:  H D Caldwell; J Kromhout; J Schachter
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

View more
  10 in total

Review 1.  Animal models for studying female genital tract infection with Chlamydia trachomatis.

Authors:  Evelien De Clercq; Isabelle Kalmar; Daisy Vanrompay
Journal:  Infect Immun       Date:  2013-07-08       Impact factor: 3.441

2.  Transcervical Inoculation with Chlamydia trachomatis Induces Infertility in HLA-DR4 Transgenic and Wild-Type Mice.

Authors:  Sukumar Pal; Delia F Tifrea; Guangming Zhong; Luis M de la Maza
Journal:  Infect Immun       Date:  2017-12-19       Impact factor: 3.441

3.  A vaccine formulated with the major outer membrane protein can protect C3H/HeN, a highly susceptible strain of mice, from a Chlamydia muridarum genital challenge.

Authors:  Sukumar Pal; Olga V Tatarenkova; Luis M de la Maza
Journal:  Immunology       Date:  2015-10-01       Impact factor: 7.397

Review 4.  Update on Chlamydia trachomatis Vaccinology.

Authors:  Luis M de la Maza; Guangming Zhong; Robert C Brunham
Journal:  Clin Vaccine Immunol       Date:  2017-04-05

5.  A Recombinant Chlamydia trachomatis MOMP Vaccine Elicits Cross-serogroup Protection in Mice Against Vaginal Shedding and Infertility.

Authors:  Delia F Tifrea; Sukumar Pal; Luis M de la Maza
Journal:  J Infect Dis       Date:  2020-01-02       Impact factor: 5.226

6.  Transcervical Mouse Infections with Chlamydia trachomatis and Determination of Bacterial Burden.

Authors:  Karthika Rajeeve; Rajeeve Sivadasan
Journal:  Bio Protoc       Date:  2020-02-05

7.  Chlamydia trachomatis In Vivo to In Vitro Transition Reveals Mechanisms of Phase Variation and Down-Regulation of Virulence Factors.

Authors:  Vítor Borges; Miguel Pinheiro; Minia Antelo; Daniel A Sampaio; Luís Vieira; Rita Ferreira; Alexandra Nunes; Filipe Almeida; Luís J Mota; Maria J Borrego; João P Gomes
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

8.  The Structural Integrity of Plasmid-Encoded Pgp3 Is Essential for Induction of Hydrosalpinx by Chlamydia muridarum.

Authors:  Yumeng Huang; Yina Sun; Tai Qin; Yuanjun Liu
Journal:  Front Cell Infect Microbiol       Date:  2019-02-05       Impact factor: 5.293

9.  First Detection of Chlamydia trachomatis 'Swedish' Variant (nvCT) in a Russian Couple with Infertility.

Authors:  Valentina Feodorova; Edgar Sultanakhmedov; Yury Saltykov; Sergey Zaitsev; Sergey Utz; Michael Corbel; Charlotte Gaydos; Thomas Quinn; Vladimir Motin
Journal:  Open Microbiol J       Date:  2018-10-18

10.  Dissemination of Chlamydia from the reproductive tract to the gastro-intestinal tract occurs in stages and relies on Chlamydia transport by host cells.

Authors:  Savannah E Howe; Nita Shillova; Vjollca Konjufca
Journal:  PLoS Pathog       Date:  2019-12-02       Impact factor: 6.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.